临床抗凝作用的新时代口服抗凝剂。

Thrombosis Pub Date : 2012-01-01 Epub Date: 2012-10-14 DOI:10.1155/2012/835356
Sophie Testa, Oriana Paoletti, Anke Zimmermann, Laura Bassi, Silvia Zambelli, Emilia Cancellieri
{"title":"临床抗凝作用的新时代口服抗凝剂。","authors":"Sophie Testa,&nbsp;Oriana Paoletti,&nbsp;Anke Zimmermann,&nbsp;Laura Bassi,&nbsp;Silvia Zambelli,&nbsp;Emilia Cancellieri","doi":"10.1155/2012/835356","DOIUrl":null,"url":null,"abstract":"<p><p>Anticoagulation Clinics (ACs) are services specialized in management of patients on anticoagulant treatment. At present, ACs manage patients chiefly on antivitamin K antagonists (AVKs), but patient population has already changed in the last few years, because of an increase of treatments with other anticoagulant drugs, which require different management systems. The strong increase in the number of patients at AC, mainly on long-term treatment, has determined the development of web management, through telemedicine systems, improving the quality of life and maintaining the same clinical quality levels. New oral anticoagulants (NOAs) have shown to be as effective as AVK antagonists in stroke prevention in atrial fibrillation and for treatment of venous thromboembolism in addition to VTE prophylaxis in orthopaedic surgery, when administered at a fixed dose, but patient adherence and compliance are crucial for good quality treatment. At present, lacking data from the real world, an oversimplification of treatment with NOAs could cause unjustified risks for patients and also a possible future underuse of good drugs. For these reasons the vigilance must be high and ACs can have a crucial role in defining which is the best management for NOA patients and how to do it, as it happened for AVKs.</p>","PeriodicalId":75222,"journal":{"name":"Thrombosis","volume":"2012 ","pages":"835356"},"PeriodicalIF":0.0000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2012/835356","citationCount":"32","resultStr":"{\"title\":\"The role of anticoagulation clinics in the era of new oral anticoagulants.\",\"authors\":\"Sophie Testa,&nbsp;Oriana Paoletti,&nbsp;Anke Zimmermann,&nbsp;Laura Bassi,&nbsp;Silvia Zambelli,&nbsp;Emilia Cancellieri\",\"doi\":\"10.1155/2012/835356\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Anticoagulation Clinics (ACs) are services specialized in management of patients on anticoagulant treatment. At present, ACs manage patients chiefly on antivitamin K antagonists (AVKs), but patient population has already changed in the last few years, because of an increase of treatments with other anticoagulant drugs, which require different management systems. The strong increase in the number of patients at AC, mainly on long-term treatment, has determined the development of web management, through telemedicine systems, improving the quality of life and maintaining the same clinical quality levels. New oral anticoagulants (NOAs) have shown to be as effective as AVK antagonists in stroke prevention in atrial fibrillation and for treatment of venous thromboembolism in addition to VTE prophylaxis in orthopaedic surgery, when administered at a fixed dose, but patient adherence and compliance are crucial for good quality treatment. At present, lacking data from the real world, an oversimplification of treatment with NOAs could cause unjustified risks for patients and also a possible future underuse of good drugs. For these reasons the vigilance must be high and ACs can have a crucial role in defining which is the best management for NOA patients and how to do it, as it happened for AVKs.</p>\",\"PeriodicalId\":75222,\"journal\":{\"name\":\"Thrombosis\",\"volume\":\"2012 \",\"pages\":\"835356\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1155/2012/835356\",\"citationCount\":\"32\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Thrombosis\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2012/835356\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2012/10/14 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thrombosis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2012/835356","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2012/10/14 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 32

摘要

抗凝门诊(ACs)是专门管理抗凝治疗患者的服务。目前,ACs主要使用抗维生素K拮抗剂(AVKs)对患者进行管理,但在过去几年中,由于其他抗凝药物治疗的增加,患者群体已经发生了变化,这需要不同的管理系统。AC患者数量的强劲增长,主要是长期治疗,决定了网络管理的发展,通过远程医疗系统,提高生活质量并保持相同的临床质量水平。新的口服抗凝剂(NOAs)已被证明在房颤卒中预防和静脉血栓栓塞治疗以及骨科手术静脉血栓栓塞预防方面与AVK拮抗剂一样有效,但患者的依从性和依从性对于高质量的治疗至关重要。目前,由于缺乏来自真实世界的数据,过度简化noa治疗可能会给患者带来不合理的风险,也可能导致未来好药物的使用不足。由于这些原因,必须保持高度警惕,ACs在确定对NOA患者的最佳管理以及如何进行管理方面发挥着至关重要的作用,就像avk一样。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The role of anticoagulation clinics in the era of new oral anticoagulants.

Anticoagulation Clinics (ACs) are services specialized in management of patients on anticoagulant treatment. At present, ACs manage patients chiefly on antivitamin K antagonists (AVKs), but patient population has already changed in the last few years, because of an increase of treatments with other anticoagulant drugs, which require different management systems. The strong increase in the number of patients at AC, mainly on long-term treatment, has determined the development of web management, through telemedicine systems, improving the quality of life and maintaining the same clinical quality levels. New oral anticoagulants (NOAs) have shown to be as effective as AVK antagonists in stroke prevention in atrial fibrillation and for treatment of venous thromboembolism in addition to VTE prophylaxis in orthopaedic surgery, when administered at a fixed dose, but patient adherence and compliance are crucial for good quality treatment. At present, lacking data from the real world, an oversimplification of treatment with NOAs could cause unjustified risks for patients and also a possible future underuse of good drugs. For these reasons the vigilance must be high and ACs can have a crucial role in defining which is the best management for NOA patients and how to do it, as it happened for AVKs.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信